Watson’s Generic Product Approved – Analyst Blog

By | January 7, 2013
0 Comment

Watson Pharmaceuticals, Inc. ( WPI ) recently announced that it gained US Food and Drug Administration (FDA) approval for its generic version of Ferring Pharmaceuticals’ Lysteda

Taken from:
Watson’s Generic Product Approved – Analyst Blog

Related posts:

  1. NVO’s Ryzodeg Approved in Japan – Analyst Blog
  2. New Product from Medtronic – Analyst Blog
  3. Glaxo’s Anthrax Drug Gets FDA Nod – Analyst Blog
  4. No Generic Zytiga Until 2016 Benefits Medivation